Related Experiment Video
Updated: Aug 10, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Severe hypoglycemia in diabetic patients: frequency, causes, prevention
Diabetes Care
|March 1, 1985
Summary
Severe hypoglycemia in diabetic patients is often caused by overtreatment and patient errors. While not all reactions are preventable, reducing insulin doses and improving patient education can lower their incidence.
Area of Science:
- Endocrinology
- Metabolic Diseases
Background:
- Severe hypoglycemia is a significant complication for patients with diabetes mellitus treated with insulin.
- Understanding the causes and incidence of severe hypoglycemic episodes is crucial for patient safety and management.
Purpose of the Study:
- To determine the frequency and causes of severe hypoglycemic episodes in a population of diabetic patients on insulin therapy.
- To investigate potential links between insulin dosage, patient errors, and glycemic control (HbA1c) in relation to hypoglycemic events.
Main Methods:
- Prospective measurement of severe hypoglycemic episodes over 12 months in approximately 400 diabetic patients (50% type 1).
- Analysis of precipitating causes, insulin dosages, and HbA1c levels in affected patients and a control group.
- Follow-up assessment of insulin dosage and HbA1c in a subgroup of hypoglycemic patients.
Main Results:
- A patient-year incidence of 8% for severe insulin reactions was observed.
- Major causes included patient errors and excessive or incorrect insulin dosing.
- Hypoglycemic patients received higher insulin doses initially, which were reduced post-event; their HbA1c levels also increased post-event.
Conclusions:
- Overtreatment by physicians and patient-related factors (errors, lack of alertness) contribute to severe hypoglycemia.
- While complete prevention is unlikely, reducing overtreatment and enhancing patient education on recognizing and responding to hypoglycemia can decrease its incidence.
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...